Evidence map›Paper›PMID 41319161›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Locus coeruleus-entorhinal cortex tract integrity is linked to plasma tau and glial fibrillary acidic protein.

Yuliya Patsyuk, Maxime Van Egroo, Elise Beckers, Elouise A Koops, Nicholas J Ashton, Shorena Janelidze, Kaj Blennow, Oskar Hansson, Henrik Zetterberg, Benedikt A Poser and 1 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Locus coeruleus-entorhinal cortex tract integrity is linked to plasma tau and glial fibrillary acidic protein.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuliya PatsyukFaculty of Health, Medicine and Life Sciences, Mental Health and Neuroscience Research Institute, Alzheimer Centre Limburg, Maastricht University, Maastricht, Netherlands.
Maxime Van EgrooFaculty of Health, Medicine and Life Sciences, Mental Health and Neuroscience Research Institute, Alzheimer Centre Limburg, Maastricht University, Maastricht, Netherlands.
Elise BeckersFaculty of Health, Medicine and Life Sciences, Mental Health and Neuroscience Research Institute, Alzheimer Centre Limburg, Maastricht University, Maastricht, Netherlands.
Elouise A KoopsAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Nicholas J AshtonDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Shorena JanelidzeClinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Kaj BlennowDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Oskar HanssonClinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Benedikt A PoserDepartment of Cognitive Neuroscience, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, Netherlands.
Heidi I L JacobsFaculty of Health, Medicine and Life Sciences, Mental Health and Neuroscience Research Institute, Alzheimer Centre Limburg, Maastricht University, Maastricht, Netherlands.

Funding

Tracking the origin of tau pathology: dovetailing (pre-)preclinical biomarker trajectoriesR01AG062559 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Heidi Irma Jacobs · 2019 to 2026
$4.8M
The wandering nerve: gateway to boost Alzheimer's disease related cognitive performanceR01AG068062 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI JACOBS, HEIDI IRMA · 2021 to 2025
$4.6M
The effects of iron on oxidative stress and Alzheimer's biomarkers in amyloid-positive and negative elderly normalR01AG068398 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHIANG, GLORIA CHIA-YI · 2020 to 2024
$2.8M
Locus coeruleus network architecture of Alzheimer's disease vulnerabilityR01AG082006 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Heidi Irma Jacobs, Jorge Sepulcre · 2023 to 2026
$2.7M
Elevated locus coeruleus metabolism as mechanism driving Alzheimer's disease pathologyR21AG074220 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI JACOBS, HEIDI IRMA · 2021 to 2022
$477k
AD Strategic Fund and the Alzheimer's Association ADSF-21-831376-CAD Strategic Fund and the Alzheimer's Association ADSF-21-831377-CAD Strategic Fund and the Alzheimer's Association ADSF-21-831381-CAD Strategic Fund and the Alzheimer's Association ADSF-24-1284328-CAlzheimer Nederland WE.03-2019-02Alzheimer's Association 23AARF-1026796Alzheimer's Association AARG-22-920434Alzheimer's Association ZEN-21-848495Alzheimer's Drug Discovery Foundation 201809-2016615Alzheimer's Drug Discovery Foundation 201809-2016862Bluefield ProjectBrightFocus Foundation A20211016FCure Alzheimer's FundEU Joint Programme - Neurodegenerative Disease Research JPND2021-00694European Union Joint Program for Neurodegenerative Disorders JPND2019-466-236European Union's Horizon Europe research and innovation programme 101053962Familjen Erling-Perssons StiftelseH2020 FET-Open AROMA 88587Hjärnfonden ALZ2022-0006Hjärnfonden FO2017-0243Hjärnfonden FO2021-0293Hjärnfonden FO2022-0270HORIZON EUROPE Marie Sklodowska-Curie Actions 101109451-ADEEPSLEEPHORIZON EUROPE Marie Sklodowska-Curie Actions 860197Knut och Alice Wallenbergs Stiftelse 2017-0383Konung Gustaf V:s och Drottning Victorias FrimurarestiftelseMarianne and Marcus Wallenberg Foundation 2015.0125National Institutes of Health (NIH) 1R01AG068398-01National Institutes of Health (NIH) R01AG062559National Institutes of Health (NIH) R01AG06806National Institutes of Health (NIH) R01AG082006National Institutes of Health (NIH) R21AG074220NIA NIH HHS R01 AG062559NIA NIH HHS R01 AG068062NIA NIH HHS R01 AG068398NIA NIH HHS R01 AG082006NIA NIH HHS R21 AG074220Olav Thon StiftelsenParkinson foundation of Sweden 1280/20Regionalt Forskningsstöd 2020-0314Skånes universitetssjukhus 2020-O000028Stiftelsen för Gamla TjänarinnorSwedish Alzheimer Foundation AF-930351Swedish Alzheimer Foundation AF-939721Swedish Alzheimer Foundation AF-939932Swedish Alzheimer Foundation AF-968270Swedish federal government under the ALF agreement 2018-Projekt0279Swedish federal government under the ALF agreement ALFGBG-715986Swedish federal government under the ALF agreement ALFGBG-965240Swedish State Support for Clinical Research ALFGBG-71320Swedish state under the agreement between the Swedish government and the County Councils, the ALF-agreement ALFGBG-71320Swedish state under the agreement between the Swedish government and the County Councils, the ALF-agreement ALFGBG-715986Swedish state under the agreement between the Swedish government and the County Councils, the ALF-agreement ALFGBG-965240UCLH Biomedical Research CentreUK Dementia Research Institute UKDRI-1003Vetenskapsrådet 2016-00906Vetenskapsrådet 2017-00915Vetenskapsrådet 2019-02397Vetenskapsrådet 2022-01018Vetenskapsrådet 2023-00356
6 · The paper itself

Abstract

introductionPretangle tau inclusions from the locus coeruleus (LC) are hypothesized to propagate to the entorhinal cortex (EC) via neuron-to-neuron transmission along its projections. The lower integrity of the LC-EC pathway accompanying Alzheimer's disease (AD) pathology is supported by post mortem studies, but in vivo evidence remains limited.

methodsWe associated diffusion-weighted 7T magnetic resonance imaging (MRI) metrics of microstructural integrity within the LC-EC tract to plasma AD-related biomarkers in a cohort of 47 cognitively unimpaired adults.

resultsWorse overall and local LC-EC integrity, indicated by lower fractional anisotropy (FA) and higher mean diffusivity (MD), was related to elevated concentrations of plasma phosphorylated tau 181 (p-tau181), p-tau217, and glial fibrillary acidic protein (GFAP). A higher orientation dispersion index (ODI) within the LC-EC tract was linked to elevated plasma p-tau181 and p-tau231 levels. DISCUSSION: The lower integrity of the LC-EC pathway may serve as a key indicator of the earliest AD-related pathophysiological processes to improve detection of at-risk individuals. HIGHLIGHTS: Standard DTI model metrics in the LC- EC tract are linked to elevated plasma p-tau and GFAP. A higher ODI in the voxels containing the LC-EC tract is related to elevated plasma p-tau. LC-EC integrity links to AD-related biomarkers show topographic specificity. Lower LC-EC integrity may be a key indicator of the earliest AD-related pathology.

Indexed as

Alzheimer DiseaseEntorhinal CortexGlial Fibrillary Acidic ProteinLocus Coeruleustau ProteinsAgedBiomarkersDiffusion Magnetic Resonance ImagingFemaleHumansMaleMiddle AgedNeural PathwaysBiomarkersGlial Fibrillary Acidic ProteinMAPT protein, humantau ProteinsAlzheimer's diseasebiomarkersdiffusion tensor imagingentorhinal cortexlocus coeruleusmagnetic resonance imagingmicrostructural integrityneurite orientation dispersion and density imagingpreclinicaltauwhite matter

Identifiers

PMID41319161
PMCPMC12665172

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.